Sunday

23rd Jul 2017

MEPs back law favouring child medicines

  • 50 per cent of drugs prescribed to children are not tested on children (Photo: www.freeimages.co.uk)

The European Parliament on Wednesday (7 September) voted in favour of a new regulation on medicine, obliging pharmaceutical companies producing a drug for adults in the EU to test whether it can also be used for children.

Named the "Regulation on Medicinal Products for Paediatric Use" the law is aimed at stemming criticism that drugs are generally only tested on adults.

Thank you for reading EUobserver!

Subscribe now and get 40% off for an annual subscription. Sale ends soon.

  1. €90 per year. Use discount code EUOBS40%
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

"For far too long Europe's children have been waiting, and parents' and patients' organisations have been calling, for special paediatric medicines. Let's not disappoint them," centre-right French MEP Francoise Grossetête wrote in a report ahead of Wednesday's vote.

As medicine is generally only tested on adults, doctors can often only estimate the dose of medicine that should be given to children.

There is also a lack of knowledge about the possible side-effects from the medicine.

Fifty per cent of drugs prescribed to children are not tested on children.

One obstacle for enhanced testing on children has been incentives to pharmaceutical companies to invest more in testing.

Medicine for children's use makes up for a minor part of the medicine market, and pharmaceutical companies have shown little interest in investing in additional tests.

In order to boost research incentives, the newly adopted law says that companies should have an extra six months of protection under existing patents.

Brian Ager, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) said he was pleased with the outcome of Wednesday's vote:

"This week's Strasbourg plenary vote is a key opportunity for Europe's children and for Europe's pharmaceutical science base", he said in a press.

But manufacturers of generic low-cost alternatives to patented medicines have protested saying high-cost companies will make too much of a profit on prolonged patents.

The regulation now has to be approved by member states before it can go into force.

Polish parliament steps up showdown with EU

Lawmakers in Poland adopted a controversial reform of the Supreme Court, despite warnings from the EU that the move could trigger a sanction procedure over the rule of law.

EU urges UK to clarify its Brexit positions

EU and UK negotiators presented their Brexit positions to identify common grounds this week, but that was made difficult by the scarcity of UK position papers.

Opinion

Winter is here for Spitzenkandidat, but he'll survive

Candidates from all political families should be presenting their vision on where the Union should be headed. European socialists want to keep the Spitzenkandidat procedure for future elections.

EU urges UK to clarify its Brexit positions

EU and UK negotiators presented their Brexit positions to identify common grounds this week, but that was made difficult by the scarcity of UK position papers.

News in Brief

  1. Polish parliament adopts controversial justice reform
  2. GMO opt-out plan unlikely to go anywhere in 2017
  3. Slovak PM threatens to boycott inferior food
  4. France takes Google's 'right to be forgotten' to EU court
  5. Turkey accuses German companies of supporting terror
  6. Israel's Netanyahu caught calling EU 'crazy'
  7. UK does not collect enough data to expel EU nationals
  8. Polish president threatens to veto justice reform

Stakeholders' Highlights

  1. European Jewish CongressJean-Marie Le Pen Faces Trial for Oven Comments About Jewish Singer
  2. ACCAAnnounces Belt & Road Research at Shanghai Conference
  3. ECPAFood waste in the field can double without crop protection. #WithOrWithout #pesticides
  4. EU2017EEEstonia Allocates €1 Million to Alleviate Migratory Pressure From Libya in Italy
  5. Dialogue PlatformFethullah Gulen's Message on the Anniversary of the Coup Attempt in Turkey
  6. Martens CentreWeeding out Fake News: An Approach to Social Media Regulation
  7. European Jewish CongressEJC Concerned by Normalisation of Antisemitic Tropes in Hungary
  8. Counter BalanceOut for Summer Episode 1: How the EIB Sweeps a Development Fiasco Under the Rug
  9. CESICESI to Participate in Sectoral Social Dialogue Committee on Postal Services
  10. ILGA-EuropeMalta Keeps on Rocking: Marriage Equality on Its Way
  11. European Friends of ArmeniaEuFoA Director and MEPs Comment on the Recent Conflict Escalation in Nagorno-Karabakh
  12. EU2017EEEstonian Presidency Kicks off Youth Programme With Coding Summer School

Latest News

  1. Dutch coalition talks lengthiest in 40 years
  2. Polish parliament steps up showdown with EU
  3. EU urges UK to clarify its Brexit positions
  4. Law expert: direct EU powers have become too complicated
  5. Winter is here for Spitzenkandidat, but he'll survive
  6. Mafia money pollutes the EU economy
  7. Central Europe should be wary of Brexit stopping
  8. Poland's 'July coup' and what it means for the judiciary